title: Nipah virus: vaccination and passive protection studies in a hamster model.
abstract: Nipah virus, a member of the paramyxovirus family, was first isolated and identified in 1999 when the virus crossed the species barrier from fruit bats to pigs and then infected humans, inducing an encephalitis with up to 40% mortality. At present there is no prophylaxis for Nipah virus. We investigated the possibility of vaccination and passive transfer of antibodies as interventions against this disease. We show that both of the Nipah virus glycoproteins (G and F) when expressed as vaccinia virus recombinants induced an immune response in hamsters which protected against a lethal challenge by Nipah virus. Similarly, passive transfer of antibody induced by either of the glycoproteins protected the animals. In both the active and passive immunization studies, however, the challenge virus was capable of hyperimmunizing the vaccinated animals, suggesting that although the virus replicates under these conditions, the immune system can eventually control the infection.
authors.affiliation: INSERM Unite 404. UBIVE, Institut Pasteur, CERVI, IFR 128, Lyon, France.
authors.forename: V
authors.initials: V
authors.lastname: Guillaume
authors.forename: H
authors.initials: H
authors.lastname: Contamin
authors.forename: P
authors.initials: P
authors.lastname: Loth
authors.forename: M-C
authors.initials: MC
authors.lastname: Georges-Courbot
authors.forename: A
authors.initials: A
authors.lastname: Lefeuvre
authors.forename: P
authors.initials: P
authors.lastname: Marianneau
authors.forename: K B
authors.initials: KB
authors.lastname: Chua
authors.forename: S K
authors.initials: SK
authors.lastname: Lam
authors.forename: R
authors.initials: R
authors.lastname: Buckland
authors.forename: V
authors.initials: V
authors.lastname: Deubel
authors.forename: T F
authors.initials: TF
authors.lastname: Wild
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000097:blood / Q000276:immunology*; D006224:Cricetinae; D004195:Disease Models, Animal; D006367:HeLa Cells; D045464:Henipavirus Infections / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007116:Immunization, Passive / Q000379:methods*; D008647:Mesocricetus; D045405:Nipah Virus / Q000276:immunology*; D014611:Vaccination / Q000379:methods; D014616:Vaccinia virus / Q000235:genetics; D014759:Viral Envelope Proteins / Q000235:genetics / Q000276:immunology; D014760:Viral Fusion Proteins / Q000235:genetics / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; D014759:Viral Envelope Proteins; D014760:Viral Fusion Proteins; D014765:Viral Vaccines